Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.

Peyrin-Biroulet, Laurent

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. [electronic resource] - World journal of gastroenterology Apr 2007 - 2328-32 p. digital

Publication Type: Clinical Trial; Journal Article

1007-9327

10.3748/wjg.v13.i16.2328 doi


Adalimumab
Adult
Anti-Inflammatory Agents--adverse effects
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
C-Reactive Protein--metabolism
Colitis, Ulcerative--blood
Drug Tolerance
Female
Humans
Infliximab
Injections, Subcutaneous
Male
Middle Aged
Prospective Studies
Remission Induction